These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 3001716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.
    Offit PA, Clark HF, Blavat G, Greenberg HB.
    J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983
    [Abstract] [Full Text] [Related]

  • 3. Analysis by RNA-RNA hybridization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
    Midthun K, Valdesuso J, Hoshino Y, Flores J, Kapikian AZ, Chanock RM.
    J Clin Microbiol; 1987 Feb; 25(2):295-300. PubMed ID: 3029162
    [Abstract] [Full Text] [Related]

  • 4. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ.
    J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
    [Abstract] [Full Text] [Related]

  • 5. Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
    Hoshino Y, Sereno MM, Midthun K, Flores J, Chanock RM, Kapikian AZ.
    J Clin Microbiol; 1987 Feb; 25(2):290-4. PubMed ID: 2434522
    [Abstract] [Full Text] [Related]

  • 6. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.
    Midthun K, Hoshino Y, Kapikian AZ, Chanock RM.
    J Clin Microbiol; 1986 Nov; 24(5):822-6. PubMed ID: 3021814
    [Abstract] [Full Text] [Related]

  • 7. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
    Hoshino Y, Jones RW, Chanock RM, Kapikian AZ.
    J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
    [Abstract] [Full Text] [Related]

  • 8. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y, Taniguchi K, Urasawa T, Urasawa S.
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification.
    Midthun K, Flores J, Taniguchi K, Urasawa S, Kapikian AZ, Chanock RM.
    J Clin Microbiol; 1987 Jul; 25(7):1269-74. PubMed ID: 3038948
    [Abstract] [Full Text] [Related]

  • 12. Antigenic mapping of the surface proteins of rhesus rotavirus.
    Shaw RD, Vo PT, Offit PA, Coulson BS, Greenberg HB.
    Virology; 1986 Dec; 155(2):434-51. PubMed ID: 2431540
    [Abstract] [Full Text] [Related]

  • 13. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
    Taniguchi K, Maloy WL, Nishikawa K, Green KY, Hoshino Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M.
    J Virol; 1988 Jul; 62(7):2421-6. PubMed ID: 2453680
    [Abstract] [Full Text] [Related]

  • 14. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.
    Brüssow H, Walther I, Fryder V, Sidoti J, Bruttin A.
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1647-58. PubMed ID: 2839600
    [Abstract] [Full Text] [Related]

  • 15. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.
    Ward RL, Knowlton DR, Schiff GM, Hoshino Y, Greenberg HB.
    J Virol; 1988 May; 62(5):1543-9. PubMed ID: 3357205
    [Abstract] [Full Text] [Related]

  • 16. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
    Coulson BS, Tursi JM, McAdam WJ, Bishop RF.
    Virology; 1986 Oct 30; 154(2):302-12. PubMed ID: 2429439
    [Abstract] [Full Text] [Related]

  • 17. Genetic reassortment between two human rotaviruses having different serotype and subgroup specificities.
    Urasawa S, Urasawa T, Taniguchi K.
    J Gen Virol; 1986 Aug 30; 67 ( Pt 8)():1551-9. PubMed ID: 2426394
    [Abstract] [Full Text] [Related]

  • 18. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.
    Ward RL, Knowlton DR, Greenberg HB, Schiff GM, Bernstein DI.
    J Virol; 1990 Jun 30; 64(6):2687-91. PubMed ID: 2159538
    [Abstract] [Full Text] [Related]

  • 19. Identification of the two rotavirus genes determining neutralization specificities.
    Offit PA, Blavat G.
    J Virol; 1986 Jan 30; 57(1):376-8. PubMed ID: 3001359
    [Abstract] [Full Text] [Related]

  • 20. Mapping of antigenic sites involved in serotype-cross-reactive neutralization on group A rotavirus outercapsid glycoprotein VP7.
    Hoshino Y, Nishikawa K, Benfield DA, Gorziglia M.
    Virology; 1994 Feb 15; 199(1):233-7. PubMed ID: 8116249
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.